English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
11 天
信达生物PD-1/IL-2α靶向抗体完成首个关键注册临床研究首例受试者给药
经济观察网讯 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Senate passes funding bill
Sworn in as Canada's PM
Second protester arrested
Texas measles outbreak
Strikes deal with DOGE
Wins longest-ever Iditarod
Pleads not guilty
Consumer sentiment drops
Permanently shuts route
‘Ted Lasso’ is coming back
ISIS leader killed in Iraq
Kupp signs with Seahawks
Gold rises to new heights
Court lifts Trump's DEI block
Laceration hazard recall
Top intelligence agency visit
Influential WY senator dies
Senate confirmation hearing
Man hit by motorcade, dies
Coffee creamer recall
Hamas to release hostage
Visits DOJ for speech
Legendary sportswriter dies
SpaceX launches Crew-10
Plane engine catches fire
March megastorm
To cut 2,000+ jobs
反馈